[Comment] Dupilumab for atopic dermatitis

20:58 EDT 4 May 2017 | The Lancet

In The Lancet, the LIBERTY AD CHRONOS study by Andrew Blauvelt and colleagues1 of long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids portends a coming revolution in the treatment of atopic dermatitis. Dupilumab seems to be for atopic dermatitis what etanercept was to psoriasis, an effective, safe treatment that might represent a quantum leap forward in our ability to help to improve the lives of patients.1 For individuals with moderate-to-severe atopic dermatitis, quality of life is greatly affected and can be worse than in patients with psoriasis.

Original Article: [Comment] Dupilumab for atopic dermatitis


More From BioPortfolio on "[Comment] Dupilumab for atopic dermatitis"

Quick Search

Relevant Topics

Dermatitis means an inflammation of the skin. Contact dermatitis is a term used when this inflammation is caused by contact with something in the environment. The changes of dermatitis seen in the skin take the form of eczema; hence it may sometimes be r...

The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...

Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...